STAT+: Amid a crush of Covid-19 research, scientists hone an AI tool to rapidly screen studies

Long before the pace of scientific publishing about Covid-19 broke land speed records, researchers were struggling to keep tabs on new studies in their fields. And to lighten the load, they’re increasingly turning to tools powered by artificial intelligence.

Researchers at Utrecht University in the Netherlands have built one such tool for a particularly labor-intensive step in the scientific process: sifting through many thousands of papers to find the ones most relevant to researchers conducting systematic reviews. Their open-source program, ASReview, is described in a new paper published Monday in Nature Machine Intelligence

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.